4.7 Review

Medicinal chemistry strategies towards the development of effective SARS-CoV-2 inhibitors

期刊

ACTA PHARMACEUTICA SINICA B
卷 12, 期 2, 页码 581-599

出版社

INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCES
DOI: 10.1016/j.apsb.2021.08.027

关键词

SARS-CoV-2; COVID-19; Antiviral drugs; Drug design; Medicinal chemistry strategies

资金

  1. Shandong Provincial Key Research and Development Project (China) [2019JZZY021011]
  2. Foreign Cultural and Educational Ex-perts Project (China) [GXL20200015001]
  3. Outstanding Youth Fund of Shandong Province (China) [ZR2020JQ31]
  4. Qilu Young Scholars Program of Shandong University
  5. Taishan Scholar Program at Shandong Province

向作者/读者索取更多资源

This article provides a brief overview of medicinal chemistry strategies for the development of effective SARS-CoV-2 inhibitors, highlighting representative examples.
Novel therapies are urgently needed to improve global treatment of SARS-CoV-2 infection. Herein, we briefly provide a concise report on the medicinal chemistry strategies towards the development of effective SARS-CoV-2 inhibitors with representative examples in different strategies from the medicinal chemistry perspective. (c) 2022 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据